Lumiradx Limited Warrant Stock Return On Asset

LumiraDx Limited Warrant fundamentals help investors to digest information that contributes to LumiraDx Limited's financial success or failures. It also enables traders to predict the movement of LumiraDx Stock. The fundamental analysis module provides a way to measure LumiraDx Limited's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to LumiraDx Limited stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

LumiraDx Limited Warrant Company Return On Asset Analysis

LumiraDx Limited's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current LumiraDx Limited Return On Asset

    
  -0.28  
Most of LumiraDx Limited's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LumiraDx Limited Warrant is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, LumiraDx Limited Warrant has a Return On Asset of -0.2804. This is 96.8% lower than that of the Biotechnology sector and 96.28% lower than that of the Health Care industry. The return on asset for all United States stocks is 100.29% higher than that of the company.

LumiraDx Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses LumiraDx Limited's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of LumiraDx Limited could also be used in its relative valuation, which is a method of valuing LumiraDx Limited by comparing valuation metrics of similar companies.
100%
LumiraDx Limited is currently under evaluation in return on asset category among its peers.

LumiraDx Fundamentals

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in LumiraDx Stock

If you are still planning to invest in LumiraDx Limited Warrant check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LumiraDx Limited's history and understand the potential risks before investing.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators